Thrombolytic therapy vs primary percutaneous intervention after ventricular fibrillation cardiac arrest due to acute ST-segment elevation myocardial infarction and its effect on outcome

American Journal of Emergency Medicine

Volumn 25, Issue 5, 2007, Pages 545-550

  Richling, Nina ^a   Herkner, Harald ^a   Holzer, Michael ^a   Riedmueller, Eva ^a   Sterz, Fritz ^a   Schreiber, Wolfgang ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOLYTIC AGENT; HEPARIN; RETEPLASE; TENECTEPLASE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BRAIN FUNCTION; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONVALESCENCE; FEMALE; FIBRINOLYTIC THERAPY; HEART ARREST; HEART VENTRICLE FIBRILLATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL; TREATMENT INDICATION; TREATMENT OUTCOME;

CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 34249733147     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2006.10.014     Document Type: Article

References (29)

1. Mackay J., and Mensah G. Atlas of heart disease and stroke (2004), World Health Organization
2. Hasdai D., Behar S., Wallentin L., Danchin N., Gitt A.K., Boersma E., et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 23 (2002) 1190-1201
3. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 329 (1993) 1615-1622
4. Spaulding C.M., Joly L.M., Rosenberg A., Monchi M., Weber S.N., Dhainaut J.F., et al. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med 336 (1997) 1629-1633
5. Brophy J.M., and Bogaty P. Primary angioplasty and thrombolysis are both reasonable options in acute myocardial infarction. Ann Intern Med 141 (2004) 292-297
6. Cannon C.P., Gibson C.M., Lambrew C.T., Shoultz D.A., Levy D., French W.J., et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 283 (2000) 2941-2947
7. Bonnefoy E., Lapostolle F., Leizorovicz A., Steg G., McFadden E.P., Dubien P.Y., et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 360 (2002) 82582-82589
8. Fischer M., Bottiger B.W., Popov-Cenic S., and Hossmann K.A. Thrombolysis using plasminogen activator and heparin reduces cerebral no-reflow after resuscitation from cardiac arrest: an experimental study in the cat. Intensive Care Med 22 (1996) 1214-1223
9. Schreiber W., Gabriel D., Sterz F., Muellner M., Kuerkciyan I., Holzer M., et al. Thrombolytic therapy after cardiac arrest and its effect on neurological outcome. Resuscitation 52 (2002) 63-69
10. Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the 'Utstein style'. Prepared by a Task Force of Representatives from the European Resuscitation Council, American Heart Association, Heart and Stroke Foundation of Canada, Australian Resuscitation Council. Resuscitation 1991;22:1-26.
11. Antman E.M., Anbe D.T., Armstrong P.W., Bates E.R., Green L.A., Hand M., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). J Am Coll Cardiol 44 (2004) 671-719
12. European Resuscitation Council. International Guidelines 2000 for CPR and ECC. A consensus on science. M. Resuscitation 46 (2000) 1-447
13. Kliegel A., Havel C., and Sterz F. Die behandlung des patienten mit herzkreislaufstillstand und nach reanimation im krankenhaus. Intensivmed 39 (2002) 13-25
14. Andersen H.R., Nielsen T.T., Rasmussen K., Thuesen L., Kelbaek H., Thayssen P., et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349 (2003) 733-742
15. Neuhaus K.L., Feuerer W., Jeep-Tebbe S., Niederer W., Vogt A., and Tebbe U. Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator. J Am Coll Cardiol 14 (1989) 1566-1569
16. Jennett B., and Bond M. Assessment of outcome after severe brain damage. Lancet 1 (1975) 480-484
17. Boersma E., Maas A.C., Deckers J.W., and Simoons M.L. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 348 (1996) 771-775
18. Vermeer F., Simoons M.L., Bar F.W., Tijssen J.G., van Domburg R.T., Serruys P.W., et al. Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase?. Circulation 74 (1986) 1379-1389
19. De Luca G., Suryapranata H., Ottervanger J.P., and Antman E.M. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 109 (2004) 1223-1225
20. Steg P.G., Bonnefoy E., Chabaud S., Lapostolle F., Dubien P.Y., Cristofini P., et al. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation 108 (2003) 2851-2856
21. Hekmatpanah J. Cerebral blood flow dynamics in hypotension and cardiac arrest. Neurology 23 (1973) 174-180
22. Bottiger B.W., Motsch J., Bohrer H., Boker T., Aulmann M., Nawroth P.P., et al. Activation of blood coagulation after cardiac arrest is not balanced adequately by activation of endogenous fibrinolysis. Circulation 92 (1995) 2572-2578
23. Crowell J.W., Sharpe G.P., Lambright R.L., and Read W.L. The mechanism of death after resuscitation following acute circulatory failure. Surgery 38 (1955) 696-702
24. Crowell J.W., and Smith E.E. Effect of fibrinolytic activation on survival and cerebral damage following periods of circulatory arrest. Am J Physiol 186 (1956) 283-285
25. Bottiger B.W., Bode C., Kern S., Gries A., Gust R., Glatzer R., et al. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet 357 (2001) 1583-1585
26. Ruiz-Bailen M., Aguayo dH., Serrano-Corcoles M.C., Diaz-Castellanos M.A., Ramos-Cuadra J.A., and Reina-Toral A. Efficacy of thrombolysis in patients with acute myocardial infarction requiring cardiopulmonary resuscitation. Intensive Care Med 27 (2001) 1050-1057
27. Voipio V., Kuisma M., Alaspaa A., Manttari M., and Rosenberg P. Thrombolytic treatment of acute myocardial infarction after out-of-hospital cardiac arrest. Resuscitation 49 (2001) 251-258
28. Kurkciyan I., Meron G., Sterz F., Mullner M., Tobler K., Domanovits H., et al. Major bleeding complications after cardiopulmonary resuscitation: impact of thrombolytic treatment. J Intern Med 253 (2003) 128-135
29. Janata K., Holzer M., Kurkciyan I., Losert H., Riedmuller E., Pikula B., et al. Major bleeding complications in cardiopulmonary resuscitation: the place of thrombolytic therapy in cardiac arrest due to massive pulmonary embolism. Resuscitation 57 (2003) 49-55